You searched for Health Technology Assessment (HTA) - Page 2 of 11 - OHE

We found for

Insight
March 2022

NICE’s severity modifier: a step in the right direction, but still a long way to go

Insight
March 2022

The NICE Health Technology Evaluation Manual: A Fresh Perspective Needed?

Insight
March 2022

Including Carer Quality of Life in Health Technology Evaluation: Are We There Yet?

Insight
March 2022

To Hell with the 3L! NICE’s Missed Opportunity to Upgrade Health Outcome Measurement

Rare-Disease-Day-tiny

Insight
February 2022

Rare Disease Day 2022

Insight
February 2022

New NICE Manual for Health Technology Evaluations: A Critical Discussion on the Most Relevant Changes (or Lack Thereof)

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Read more

© WellcomeCollection

News
November 2021

Opportunity Cost in Health Care: a Favourite Research Topic for OHE

Insight
June 2021

Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?

Insight
April 2021

Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?

Insight
April 2021

Reconciling MCDA and Augmented Cost-Effectiveness Analysis: Do We Get the Same Decisions?

Insight
February 2021

‘HispaNICE’: the Creation of an ‘Independent Authority for the Evaluation of Health Practices and Policies’ Gathers Momentum

It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?

Read more

Payment Models for Multi-Indication Therapies

Read more

© Photology1971/Shutterstock

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

Read more

A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases

Read more

01
02
03
04
05
06
00